The Leprosy Bacillus, circa 1873

A scientist’s desperate attempts to prove that Mycobacterium leprae causes leprosy landed him on trial, but his insights into the disease’s pathology were eventually vindicated.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

INFECTIOUS AGENTS: Gerhard Armauer Hansen observed Mycobacterium leprae for the first time in infected nodules excised from leprosy patients. Barely distinct, rod-shaped bacteria (purple) became apparent under Hansen’s microscope. However, it took German bacteriologist Albert Neisser’s stain for the bacterium, developed after visiting Hansen in 1879, to make M. leprae clearly visible. Pictured are illustrations of M. leprae-infected cells from a testicle, taken from Hansen’s 1895 book Leprosy: In its Clinical and Pathological Aspects.WELLCOME LIBRARY, LONDONNorwegian physician Gerhard Armauer Hansen first saw rod-shaped microbes in samples harvested from leprosy patients in 1873. Seven years later, Hansen, who worked in the leprosy hospital in the coastal town of Bergen, was on trial for attempting to infect a patient with bacteria without permission, using a cataract knife to inoculate a woman’s eye with material from leprous lesions.

Hansen resorted to such an extreme measure because he was having trouble proving his conviction that the microbes caused leprosy—which results in peripheral nerve damage and skin lesions—and that the disease was infectious. He had tried in vain to infect rabbits and to cultivate the microbe in vitro—evidence considered necessary to prove contagiousness. “Leprosy was afterwards called the least contagious of contagious diseases,” says Tony Gould, author of A Disease Apart: Leprosy in the Modern World, which might explain why Hansen had struggled to come up with the necessary proof.

Hansen’s unfortunate patient, a 33-year-old woman named Kari Nielsdatter, already had tuberculoid leprosy, one form of the disease, but Hansen hoped to infect her with a second form, called lepromatous leprosy. The infection did not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies